Royce Global Trust (NYSE: RGT) as of Jun 30, 2025

04:01pm, Wednesday, 30'th Jul 2025
NEW YORK , July 30, 2025 /PRNewswire/ -- A closed-end fund that invests in global equities using a disciplined value approach Average weekly trading volume of approximately 64,166 shares Fund's advise
Royce Global Trust (RGT) offers unique global small-cap exposure in a closed-end fund wrapper. The fund trades at a deep discount, but it is no bargain, as this is a regular occurrence. One of the rea

Royce Global Trust (NYSE: RGT) as of Mar 31, 2025

02:24pm, Thursday, 24'th Apr 2025
NEW YORK , April 24, 2025 /PRNewswire/ -- A closed-end fund that invests in global equities using a disciplined value approach Average weekly trading volume of approximately 94,690 shares Fund's advis
Strategic Expansion Paired with Over $1M in Annual Cost Savings from Operational Restructuring PERTH, Australia , April 23, 2025 /PRNewswire/ -- Argent BioPharma Ltd. (ASX: RGT) (OTCQB: RGTLF), a cli

Royce Global Trust (NYSE: RGT) as of Feb 28, 2025

02:00pm, Thursday, 27'th Mar 2025
NEW YORK , March 27, 2025 /PRNewswire/ -- A closed-end fund that invests in global equities using a disciplined value approach Average weekly trading volume of approximately 33,066 shares Fund's advis
PERTH, Australia , March 16, 2025 /PRNewswire/ -- Argent BioPharma Ltd. (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative t
Advanced wound care market projected to exceed $15 billion globally by 2030 PERTH, Australia , Feb. 12, 2025 /PRNewswire/ -- Argent BioPharma Ltd. (ASX: RGT) (OTCQB: RGTLF) has made significant progr
NEW YORK , Jan. 27, 2025 /PRNewswire/ --  A closed-end fund that invests in global equities using a disciplined value approach Average weekly trading volume of approximately 72,971 shares Fund's advi

Argent BioPharma Ltd. Raised US$4,500,000

06:23am, Tuesday, 07'th Jan 2025
PERTH, Australia , Jan. 7, 2025 /PRNewswire/ -- Argent BioPharma (ASX:RGT) (OTCQB:RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments
PERTH, Australia , Jan. 6, 2025 /PRNewswire/ -- Argent BioPharma (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatmen
NEW YORK , Dec. 2, 2024 /PRNewswire/ -- Royce Global Trust, Inc. (NYSE-RGT) (the "Fund") has declared a year-end distribution of $0.47 per share on its Common Stock.  The distribution, optionally pay

Royce Global Trust (NYSE: RGT) as of Oct 31, 2024

11:48am, Wednesday, 20'th Nov 2024
NEW YORK , Nov. 20, 2024 /PRNewswire/ -- A closed-end fund that invests in global equities using a disciplined value approach Average weekly trading volume of approximately 27,933 shares Fund's advise
NEW YORK , Oct. 28, 2024 /PRNewswire/ --  A closed-end fund that invests in global equities using a disciplined value approach Average weekly trading volume of approximately 28,421 shares Fund's advi

Royce Global Trust (NYSE: RGT) as of Jul 31, 2024

12:39pm, Wednesday, 28'th Aug 2024
NEW YORK , Aug. 28, 2024 /PRNewswire/ -- A closed-end fund that invests in global equities using a disciplined value approach Average weekly trading volume of approximately 23,890 shares Fund's advise
NEW YORK , May 28, 2024 /PRNewswire/ -- A closed-end fund that invests in global equities using a disciplined value approach Average weekly trading volume of approximately 48,212 shares Fund's adviser
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE